Blue Fin Capital’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.01M Buy
11,845
+522
+5% +$46.5K 0.17% 76
2025
Q4
$895K Sell
11,323
-867
-7% -$68K 0.14% 84
2025
Q3
$974K Sell
12,190
-69
-0.6% -$5.89K 0.15% 80
2025
Q2
$1.11M Buy
12,259
+127
+1% +$11.6K 0.19% 73
2025
Q1
$1.14M Sell
12,132
-79
-0.6% -$7.07K 0.22% 74
2024
Q4
$1.11M Sell
12,211
-165
-1% -$15.7K 0.2% 73
2024
Q3
$1.28M Sell
12,376
-147
-1% -$15K 0.24% 67
2024
Q2
$1.22M Buy
12,523
+163
+1% +$15K 0.24% 66
2024
Q1
$1.11M Sell
12,360
-271
-2% -$23K 0.25% 69
2023
Q4
$1.01M Sell
12,631
-46
-0.4% -$3.46K 0.26% 69
2023
Q3
$902K Buy
12,677
+128
+1% +$9.57K 0.26% 70
2023
Q2
$967K Buy
12,549
+141
+1% +$10.9K 0.28% 72
2023
Q1
$1M Sell
12,408
-101
-0.8% -$7.51K 0.32% 65
2022
Q4
$986K Sell
12,509
-78
-0.6% -$5.85K 0.36% 62
2022
Q3
$884K Sell
12,587
-2
-0% -$157 0.33% 62
2022
Q2
$1.01M Sell
12,589
-77
-0.6% -$6.02K 0.36% 63
2022
Q1
$960K Sell
12,666
-24
-0.2% -$1.9K 0.28% 68
2021
Q4
$1.08M Sell
12,690
-337
-3% -$26.3K 0.3% 68
2021
Q3
$984K Sell
13,027
-155
-1% -$12.3K 0.3% 67
2021
Q2
$1.07M Sell
13,182
-303
-2% -$24.8K 0.33% 64
2021
Q1
$1.06M Sell
13,485
-638
-5% -$50K 0.36% 64
2020
Q4
$1.21M Buy
14,123
+362
+3% +$29.9K 0.43% 60
2020
Q3
$1.06M Sell
13,761
-5,143
-27% -$392K 0.43% 61
2020
Q2
$1.38M Buy
18,904
+472
+3% +$33.5K 0.61% 44
2020
Q1
$1.22M Sell
18,432
-13
-0.1% -$917 0.68% 45
2019
Q4
$1.27M Sell
18,445
-208
-1% -$14.2K 0.6% 49
2019
Q3
$1.37M Sell
18,653
-606
-3% -$44K 0.72% 41
2019
Q2
$1.38M Buy
19,259
+70
+0.4% +$4.97K 0.71% 44
2019
Q1
$1.31M Buy
19,189
+92
+0.5% +$5.94K 0.69% 46
2018
Q4
$1.14M Sell
19,097
-1,096
-5% -$68.6K 0.68% 48
2018
Q3
$1.35M Sell
20,193
-511
-2% -$34K 0.67% 43
2018
Q2
$1.34M Sell
20,704
-848
-4% -$55.5K 0.72% 37
2018
Q1
$1.54M Hold
21,552
0.87% 31
2017
Q4
$1.63M Sell
21,552
-429
-2% -$31.3K 0.95% 27
2017
Q3
$1.6M Buy
21,981
+359
+2% +$25.9K 0.98% 28
2017
Q2
$1.6M Sell
21,622
-987
-4% -$73.3K 1.03% 29
2017
Q1
$1.66M Sell
22,609
-880
-4% -$61.6K 1.01% 31
2016
Q4
$1.54M Buy
23,489
+3,496
+17% +$240K 1.02% 31
2016
Q3
$1.48M Sell
19,993
-975
-5% -$72.1K 1.2% 23
2016
Q2
$1.53M Sell
20,968
-420
-2% -$29.9K 1.27% 23
2016
Q1
$1.51M Sell
21,388
-3,572
-14% -$238K 1.29% 22
2015
Q4
$1.66M Sell
24,960
-1,200
-5% -$79.8K 1.28% 21
2015
Q3
$1.66M Buy
26,160
+450
+2% +$29.4K 1.29% 19
2015
Q2
$1.68M Buy
25,710
+730
+3% +$49.5K 1.21% 20
2015
Q1
$1.73M Sell
24,980
-10
-0% -$691 1.25% 21
2014
Q4
$1.73M Sell
24,990
-650
-3% -$43.9K 1.3% 20
2014
Q3
$1.67M Buy
25,640
+565
+2% +$37.3K 1.33% 20
2014
Q2
$1.71M Buy
25,075
+280
+1% +$18.8K 1.37% 17
2014
Q1
$1.61M Sell
24,795
-130
-0.5% -$8.19K 1.42% 20
2013
Q4
$1.63M Buy
+24,925
New +$1.6M 1.45% 18

Other funds holding CL

Blue Fin Capital's CL Position: Q1 2026 in Review

Blue Fin Capital increased its Colgate-Palmolive (CL) stake by 4.6% in Q1 2026, buying an estimated $46.5K and bringing the position to 11,845 shares worth $1.01M. The position accounts for 0.17% of the portfolio, ranked #76.

Blue Fin Capital first reported a position in CL in Q4 2013 and has held it in 50 quarters since. The position peaked at $1.73M in Q1 2015. 1,948 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Blue Fin Capital held 11,845 shares of Colgate-Palmolive worth $1.01M as of Q1 2026.
  • Blue Fin Capital bought 522 Colgate-Palmolive shares in Q1 2026, an estimated $46.5K.
  • Colgate-Palmolive made up 0.17% of Blue Fin Capital's portfolio in Q1 2026, its #76 holding.
  • Blue Fin Capital first reported a position in Colgate-Palmolive in Q4 2013 and has held it in 50 quarters since.
  • Blue Fin Capital's Colgate-Palmolive position peaked at $1.73M in Q1 2015.
  • 1,948 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Blue Fin Capital's 13F filing for Q1 2026, filed 28 May 2026.